DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,480,813 | +18.5% | 78,520 | +14.7% | 0.05% | +20.9% |
| Q2 2023 | $16,434,000 | -48.4% | 68,475 | -45.8% | 0.04% | -50.6% |
| Q1 2023 | $31,854,832 | -31.3% | 126,388 | -27.6% | 0.09% | -35.1% |
| Q4 2022 | $46,350,559 | +2.8% | 174,631 | +0.1% | 0.13% | -8.2% |
| Q3 2022 | $45,084,000 | +6.3% | 174,543 | +4.4% | 0.15% | +10.6% |
| Q2 2022 | $42,397,000 | -78.9% | 167,243 | -75.6% | 0.13% | -72.1% |
| Q1 2022 | $200,698,000 | -6.7% | 684,207 | +4.6% | 0.47% | +3.3% |
| Q4 2021 | $215,136,000 | +16.0% | 653,884 | +7.4% | 0.46% | +11.4% |
| Q3 2021 | $185,402,000 | +18.9% | 608,990 | +4.8% | 0.41% | +18.8% |
| Q2 2021 | $155,947,000 | +35.4% | 581,104 | +13.6% | 0.35% | +21.8% |
| Q1 2021 | $115,181,000 | +6.0% | 511,731 | +4.6% | 0.28% | -0.4% |
| Q4 2020 | $108,628,000 | +471.1% | 489,011 | +453.6% | 0.28% | +383.1% |
| Q3 2020 | $19,020,000 | +2.7% | 88,330 | -15.6% | 0.06% | -6.3% |
| Q2 2020 | $18,514,000 | +118.8% | 104,706 | +71.3% | 0.06% | +85.3% |
| Q1 2020 | $8,461,000 | -46.8% | 61,141 | -41.0% | 0.03% | -33.3% |
| Q4 2019 | $15,910,000 | -26.4% | 103,653 | -30.8% | 0.05% | -32.9% |
| Q3 2019 | $21,626,000 | +16.4% | 149,728 | +15.1% | 0.08% | +15.2% |
| Q2 2019 | $18,587,000 | +1.0% | 130,057 | -6.7% | 0.07% | -2.9% |
| Q1 2019 | $18,396,000 | +56.6% | 139,354 | +22.2% | 0.07% | +28.3% |
| Q4 2018 | $11,749,000 | -18.9% | 114,012 | -14.5% | 0.05% | -7.0% |
| Q3 2018 | $14,492,000 | +59.6% | 133,342 | +44.9% | 0.06% | +39.0% |
| Q2 2018 | $9,081,000 | -3.2% | 92,016 | -4.0% | 0.04% | -6.8% |
| Q1 2018 | $9,381,000 | -1.0% | 95,808 | -6.1% | 0.04% | -10.2% |
| Q4 2017 | $9,471,000 | +33.3% | 102,029 | +23.2% | 0.05% | +11.4% |
| Q3 2017 | $7,107,000 | +2.5% | 82,842 | +0.9% | 0.04% | -2.2% |
| Q2 2017 | $6,931,000 | +31.4% | 82,127 | +33.2% | 0.04% | +28.6% |
| Q1 2017 | $5,273,000 | +62.5% | 61,637 | +47.9% | 0.04% | +40.0% |
| Q4 2016 | $3,245,000 | +41.1% | 41,681 | +42.1% | 0.02% | +47.1% |
| Q3 2016 | $2,300,000 | -15.5% | 29,342 | +8.8% | 0.02% | -19.0% |
| Q2 2016 | $2,723,000 | +6.5% | 26,959 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $2,557,000 | +2.1% | 26,959 | 0.0% | 0.02% | 0.0% |
| Q4 2015 | $2,504,000 | -35.9% | 26,959 | -41.2% | 0.02% | -30.0% |
| Q3 2015 | $3,907,000 | -0.4% | 45,850 | 0.0% | 0.03% | 0.0% |
| Q2 2015 | $3,924,000 | +49.9% | 45,850 | +48.7% | 0.03% | +50.0% |
| Q1 2015 | $2,618,000 | -1.9% | 30,838 | -1.0% | 0.02% | +5.3% |
| Q4 2014 | $2,669,000 | -16.1% | 31,154 | -25.6% | 0.02% | -17.4% |
| Q3 2014 | $3,181,000 | -11.3% | 41,858 | -8.1% | 0.02% | -11.5% |
| Q2 2014 | $3,586,000 | +22.1% | 45,558 | +16.3% | 0.03% | +13.0% |
| Q1 2014 | $2,938,000 | +1.0% | 39,164 | +3.9% | 0.02% | -4.2% |
| Q4 2013 | $2,910,000 | +23.2% | 37,682 | +10.6% | 0.02% | +4.3% |
| Q3 2013 | $2,362,000 | -1.3% | 34,085 | -9.9% | 0.02% | -4.2% |
| Q2 2013 | $2,393,000 | – | 37,820 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |